These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 29766510

  • 21. Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease.
    Parra I, Martínez I, Ramírez-García G, Tizabi Y, Mendieta L.
    Neurotox Res; 2020 Jan; 37(1):1-11. PubMed ID: 31478124
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
    Singh S, Mishra A, Shukla S.
    Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
    [Abstract] [Full Text] [Related]

  • 24. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
    Zheng L, Wang H, Ba YY, Liu HL, Wang M, Guo WW, Wu X, Yang H.
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
    Migliore MM, Ortiz R, Dye S, Campbell RB, Amiji MM, Waszczak BL.
    Neuroscience; 2014 Aug 22; 274():11-23. PubMed ID: 24845869
    [Abstract] [Full Text] [Related]

  • 28. SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats.
    Chen L, Deltheil T, Turle-Lorenzo N, Liberge M, Rosier C, Watabe I, Sreng L, Amalric M, Mourre C.
    Int J Neuropsychopharmacol; 2014 Aug 22; 17(8):1295-306. PubMed ID: 24661728
    [Abstract] [Full Text] [Related]

  • 29. Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson's disease.
    Kumari R, Kumar JB, Luthra PM.
    Neurosci Lett; 2015 Mar 04; 589():191-5. PubMed ID: 25528406
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C).
    Smith GA, Rocha EM, Rooney T, Barneoud P, McLean JR, Beagan J, Osborn T, Coimbra M, Luo Y, Hallett PJ, Isacson O.
    PLoS One; 2015 Mar 04; 10(3):e0121072. PubMed ID: 25815475
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Behavioural effects of trishomocubanes in rats with unilateral 6-hydroxydopamine lesions.
    van Dijk A, Johnston C, Allbutt H, Kassiou M, Henderson J.
    Behav Brain Res; 2008 Jun 26; 190(1):14-21. PubMed ID: 18378329
    [Abstract] [Full Text] [Related]

  • 36. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H, Jia L, Chen X, Shi L, Xie J.
    Brain Res Bull; 2018 Mar 26; 137():132-139. PubMed ID: 29174294
    [Abstract] [Full Text] [Related]

  • 37. Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease.
    Thornton E, Vink R.
    PLoS One; 2012 Mar 26; 7(4):e34138. PubMed ID: 22485158
    [Abstract] [Full Text] [Related]

  • 38. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.
    Neurobiol Dis; 2006 May 26; 22(2):421-34. PubMed ID: 16480889
    [Abstract] [Full Text] [Related]

  • 39. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY, Lee JE, Park JH, Shin IC, Koh HC.
    Toxicol Lett; 2012 Sep 18; 213(3):332-44. PubMed ID: 22842585
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.